Skip to main content

Peer Review reports

From: COXIBs and 2,5-dimethylcelecoxib counteract the hyperactivated Wnt/β-catenin pathway and COX-2/PGE2/EP4 signaling in glioblastoma cells

Original Submission
27 May 2020 Submitted Original manuscript
15 Jul 2020 Reviewed Reviewer Report
24 Jul 2020 Reviewed Reviewer Report
17 Oct 2020 Author responded Author comments - Aleksandra Majchrzak-Celińska
Resubmission - Version 2
17 Oct 2020 Submitted Manuscript version 2
14 Nov 2020 Reviewed Reviewer Report
6 Dec 2020 Reviewed Reviewer Report
15 Jan 2021 Author responded Author comments - Aleksandra Majchrzak-Celińska
Resubmission - Version 3
15 Jan 2021 Submitted Manuscript version 3
23 Feb 2021 Author responded Author comments - Aleksandra Majchrzak-Celińska
Resubmission - Version 4
23 Feb 2021 Submitted Manuscript version 4
15 Mar 2021 Reviewed Reviewer Report - Benjamin Benzon
15 Mar 2021 Reviewed Reviewer Report - Fátima Baltazar
20 Mar 2021 Author responded Author comments - Aleksandra Majchrzak-Celińska
Resubmission - Version 5
20 Mar 2021 Submitted Manuscript version 5
30 Mar 2021 Author responded Author comments - Aleksandra Majchrzak-Celińska
Resubmission - Version 6
30 Mar 2021 Submitted Manuscript version 6
2 Apr 2021 Author responded Author comments - Aleksandra Majchrzak-Celińska
Resubmission - Version 7
2 Apr 2021 Submitted Manuscript version 7
7 Apr 2021 Author responded Author comments - Aleksandra Majchrzak-Celińska
Resubmission - Version 8
7 Apr 2021 Submitted Manuscript version 8
Publishing
8 Apr 2021 Editorially accepted
3 May 2021 Article published 10.1186/s12885-021-08164-1

You can find further information about peer review here.

Back to article page